Navigation Links
MedClean Technologies Announces Results of Private Exchange Offer
Date:7/8/2009

BETHEL, Conn., July 8 /PRNewswire-FirstCall/ -- MedClean Technologies, Inc. (OTC Bulletin Board: MCLN) announced today the results of its private offer to exchange all of the Company's existing Common Stock Purchase Warrants with Initial Exercise Dates between July 11, 2008 and August 29, 2008 ("Existing Warrants") for newly issued Common Stock Purchase Warrants with a new lower exercise price of $0.0075 per share, exercisable for one-half the original number of shares of our common stock, par value $0.0001 per share ("Common Stock"), and without a "cashless exercise" right.

The Offer to Exchange expired at 5:00 p.m., Eastern Standard Time, on June 30, 2009 (the "Expiration Time").

As of the Expiration Time the Company received Existing Warrants for exchange representing 334,838,221 shares of Common Stock, a 92% success rate for the Offer to Exchange. From and after the Expiration Time there will be outstanding the following Common Stock Purchase Warrants with Initial Exercise Dates between July 11, 2008 and August 29, 2008:

  • Common Stock Purchase Warrants for the purchase of 167,419,111 shares of Common Stock with an exercise price of $0.0075 per share
  • Common Stock Purchase Warrants for the purchase of 28,000,000 shares of Common Stock with an exercise price of $0.025 per share

About MedClean Technologies, Inc.

MedClean Technologies, Inc. is a provider of innovative technology and services for the onsite treatment and disposal of regulated medical waste. MedClean's flagship MedClean(R) Series systems are fully integrated, turnkey technology solutions that enable hospitals and other healthcare providers to safely, efficiently and cost-effectively convert bio-hazardous regulated medical waste into sterile, unrecognizable material suitable for disposal as municipal solid waste. MedClean was founded in 1997 with corporate headquarters, research and development and distribution facilities located in Bethel, Connecticut. Further information on MedClean can be found at http://www.medcleantechnologies.com and in filings with the Securities and Exchange Commission found at http://www.sec.gov.

Statements about our future expectations are "forward-looking statements" within the meaning of applicable Federal Securities Laws, and are not guarantees of future performance. When used herein, the words "may," "will," "should," "anticipate," "believe," "appear," "intend," "plan," "expect," "estimate," "approximate," and similar expressions are intended to identify such forward-looking statements. These statements involve risks and uncertainties inherent in our business, including those set forth in our most recent Annual Report on Form 10-K for the year ended December 31, 2008, filed with the SEC on March 24, 2009, and other filings with the SEC, and are subject to change at any time. Our actual results could differ materially from these forward-looking statements. We undertake no obligation to update publicly any forward-looking statement.

        Contacts:
        MedClean Technologies, Inc.               Investor Contact:
        Sean Macpherson                           Cameron Donahue
        Corporate Secretary                       Hayden IR
        (203) 798-1080                            (651) 653-1854


'/>"/>
SOURCE MedClean Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. MedClean Technologies Inc. Announces New Ticker Symbol
2. MedClean Technologies Inc. CEO Publishes Letter to Shareholders
3. MedClean Technologies, Inc. Announces $1 Million Order
4. MedClean Technologies, Inc. Awarded MedAssets Supply Chain Systems Contract
5. MedClean Technologies, Inc. Approved in New Jersey
6. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
7. Cardiovascular Technologies to be Highlighted at 5th Annual Cleveland Clinic Medical Innovation Summit, Oct. 1-3
8. VNUS Medical Technologies Announces Resignation of Chief Financial Officer and VP, Finance & Administration
9. Osteotech to Present at First Albany Capitals Regenerative Technologies Conference in New York
10. ReBuilder Medical Technologies, Inc. Reports International Sales Expansion
11. Advanced technologies aim to transform the coaching of top athletes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2017)... ... ... In 2014, Harvard researchers published a report suggesting a link ... researchers found that men who had undergone a vasectomy were 10% more likely to ... increased risks are small, they seem to be contradicted by epidemiology findings published in ...
(Date:2/28/2017)... ... February 28, 2017 , ... BrightStar Care Marietta announced that it has received ... Pulse. This award is granted only to top-ranking home care providers, based on client ... ranked among home care providers from across the country who have proven their ability ...
(Date:2/27/2017)... ... February 27, 2017 , ... It’s no secret that aging ... to a host of health issues, including urinary incontinence. However, results published in ... that good overall muscle strength in older women, particularly in the abdominal and ...
(Date:2/27/2017)... Fla. (PRWEB) , ... February 27, 2017 , ... Much ... but concern for women who become dependent on opioid painkillers has fallen short. From ... patients, compared to a 237% increase in fatal overdoses in male populations.(1) , The ...
(Date:2/27/2017)... ... February 27, 2017 , ... This ... laser diffraction analysis as a tool to characterize particle size distributions in the ... obtain improved results and novel scientific findings. It describes methods of optimized and ...
Breaking Medicine News(10 mins):
(Date:2/28/2017)... The global  pulse oximeters market  is expected to reach USD 2.8 ... The pulse oximeters market is anticipated to witness significant growth during the forecast ... as chronic obstructive pulmonary disease (COPD), sleep apnea, cardiac arrhythmia, and ischemic conditions. ... ... Grand View Research Logo ...
(Date:2/28/2017)... This report provides all the information you require to ... since 2010. Download the full report: ... Alliance since 2010 report provides an in-depth insight into ... life sciences companies. On demand company reports ... most up to date deal and company data. ...
(Date:2/28/2017)... , Feb 28, 2017 ... Research and Markets ... 2025" report to their offering. The global ... The orthobiologics market is predominantly driven by ... technological innovations in biomaterials, used in the production of orthobiologics are ...
Breaking Medicine Technology: